Hall Bill Labels Products ‘Derived From Research Using’ Fetal Tissue

The text as introduced · 587 words

89R2547 KKR-D

By: Hall
S.B. No. 122

A BILL TO BE ENTITLED

AN ACT

relating to required labeling of certain products containing or

derived from aborted human fetal tissue.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter D, Chapter 431, Health and Safety

Code, is amended by adding Section 431.085 to read as follows:

Sec. 431.085. LABELING REQUIRED FOR FETAL TISSUE FOOD

PRODUCT. (a) In this section:

(1) "Fetal tissue food product" means a food or food

additive that:

(A) contains human fetal tissue;

(B) is manufactured using human fetal tissue; or

(C) is otherwise derived from research using

human fetal tissue.

(2) "Human fetal tissue" means tissue, cells,

including cells from fetal cell lines, or organs obtained or

originally derived from an aborted unborn child.

(b) A person may not sell in this state a fetal tissue food

product unless the product is clearly and conspicuously labeled in

accordance with department rules.

(c) The executive commissioner by rule shall prescribe the

form and contents of the label required by Subsection (b).

SECTION 2. Subchapter E, Chapter 431, Health and Safety

Code, is amended by adding Section 431.118 to read as follows:

Sec. 431.118. LABELING REQUIRED FOR FETAL TISSUE MEDICAL

PRODUCT. (a) In this section:

(1) "Fetal tissue medical product" means a medication,

vaccine, or other medical product used in medical treatment that:

(A) contains human fetal tissue;

(B) is manufactured using human fetal tissue; or

(C) is otherwise derived from research using

human fetal tissue.

(2) "Human fetal tissue" means tissue, cells,

including cells from fetal cell lines, or organs obtained or

originally derived from an aborted unborn child.

(b) A person may not sell, dispense, or administer in this

state a fetal tissue medical product unless the product is clearly

and conspicuously labeled in accordance with department rules.

(c) The executive commissioner by rule shall prescribe the

form and contents of the label required by Subsection (b).

SECTION 3. Subchapter F, Chapter 431, Health and Safety

Code, is amended by adding Section 431.143 to read as follows:

Sec. 431.143. LABELING REQUIRED FOR FETAL TISSUE COSMETIC

PRODUCT. (a) In this section:

(1) "Fetal tissue cosmetic product" means a cosmetic

product that:

(A) contains human fetal tissue;

(B) is manufactured using human fetal tissue; or

(C) is otherwise derived from research using

human fetal tissue.

(2) "Human fetal tissue" means tissue, cells,

including cells from fetal cell lines, or organs obtained or

originally derived from an aborted unborn child.

(b) A person may not sell in this state a fetal tissue

cosmetic product unless the product is clearly and conspicuously

labeled in accordance with department rules.

(c) The executive commissioner by rule shall prescribe the

form and contents of the label required by Subsection (b).

SECTION 4. (a) Not later than December 1, 2025, the

executive commissioner of the Health and Human Services Commission

shall adopt the form and content of the labels required under

Sections 431.085, 431.118, and 431.143, Health and Safety Code, as

added by this Act.

(b) Sections 431.085, 431.118, and 431.143, Health and

Safety Code, as added by this Act, apply only to a fetal tissue

product sold, dispensed, or administered on or after January 1,

2026.

SECTION 5. This Act takes effect immediately if it receives

a vote of two-thirds of all the members elected to each house, as

provided by Section 39, Article III, Texas Constitution. If this

Act does not receive the vote necessary for immediate effect, this

Act takes effect September 1, 2025.